From Breast to Prostate Cancer Stem Cells:
Advancing Natural Cancer Research
The inaugural Beljanski Integrative Cancer Conference fully funded a groundbreaking research project on breast cancer stem cells in partnership with Kansas University Medical Center. This study focused on testing natural compounds’ (Pao pereira, Rauwolfia vomitoria and a select mix of green teas) ability to combat these aggressive cells, which are known to resist chemotherapy, self-renew, and drive tumor progression.
The results of this pivotal research will be unveiled at the 2025 Beljanski Integrative Cancer Conference. Could this be the breakthrough that ends breast cancer relapse? Will these findings have implications for prostate cancer as well? Building on the success of this research, the 2025 conference will launch the next phase: testing the same extracts on prostate cancer stem cells. Our goal is to raise $240,000 to fully fund this new study, advancing natural cancer treatment even further.
WORKING TO CURE CANCER
THE NATURAL WAY
Studying natural compounds against cancer stem cells is valuable because it could lead to the development of more effective, less toxic, and affordable treatments for cancer, ultimately improving the outcomes for patients. Natural compounds offer several advantages over traditional chemotherapies: they are often less toxic and have fewer side effects, making them more suitable for long-term use. Additionally, natural compounds are generally more readily available and affordable than synthetic drugs. Finally, they have the potential to be used in combination with other treatments, such as radiation or chemotherapy, to enhance their effectiveness.
This research approach bridges the gap between traditional medicine and innovative natural therapies, providing new strategies to improve patient outcomes.
The Beljanski Foundation is a 501 (c)(3) whose mission is to study and share knowledge of effective, non-toxic, natural answers that work both alone and in synergy with traditional western medicine to cure cancer and other chronic diseases the natural way.
In partnership with Kansas University Medical Center, the Foundation has led multiple successful research programs, including studies on pancreatic cancer stem cells. The inaugural conference enabled a breast cancer research project, and the exciting results from that study will be presented at the 2025 conference.
The 2025 conference marks the beginning of our next major initiative: targeting prostate cancer stem cells using the same plant extracts tested on breast cancer. With your support, we aim to raise $240,000 to fund this critical research and continue our fight against cancer.
Attend the 2025 Beljanski Integrative Cancer Conference to be the first to hear the groundbreaking results of our breast cancer research and help us launch the next phase focused on prostate cancer.
If you are unable to attend, you can still make a difference by donating to this important cause. Every contribution brings us closer to our goal of $240,000, supporting research that could change lives and improve cancer treatment for future generations.